Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery (PENELOPE-B)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01864746
Recruitment Status : Active, not recruiting
First Posted : May 30, 2013
Last Update Posted : February 28, 2018
Sponsor:
Collaborators:
Pfizer
AGO Study Group
NSABP Foundation Inc
Breast International Group
Information provided by (Responsible Party):
German Breast Group

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 2020
  Estimated Study Completion Date : November 2023
Publications: